These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7846734)

  • 1. Alterations in estradiol metabolism in MCF-7 cells induced by treatment with indole-3-carbinol and related compounds.
    Niwa T; Swaneck G; Bradlow HL
    Steroids; 1994 Sep; 59(9):523-7. PubMed ID: 7846734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abrogation of estrogen-mediated cellular and biochemical effects by indole-3-carbinol.
    Ashok BT; Chen Y; Liu X; Bradlow HL; Mittelman A; Tiwari RK
    Nutr Cancer; 2001; 41(1-2):180-7. PubMed ID: 12094623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent.
    Tiwari RK; Guo L; Bradlow HL; Telang NT; Osborne MP
    J Natl Cancer Inst; 1994 Jan; 86(2):126-31. PubMed ID: 8271295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of proliferation and modulation of estradiol metabolism: novel mechanisms for breast cancer prevention by the phytochemical indole-3-carbinol.
    Telang NT; Katdare M; Bradlow HL; Osborne MP; Fishman J
    Proc Soc Exp Biol Med; 1997 Nov; 216(2):246-52. PubMed ID: 9349693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-estrogenic activity of indole-3-carbinol in neonatal rat osteoblasts is associated with the estrogen receptor antagonist 2-hydroxyestradiol.
    Enríquez J; Velázquez-Cruz R; Parra-Torres A; Gutiérrez-Sagal R; Larrea F
    J Endocrinol Invest; 2016 Oct; 39(10):1149-58. PubMed ID: 27312859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer.
    Ashok BT; Chen YG; Liu X; Garikapaty VP; Seplowitz R; Tschorn J; Roy K; Mittelman A; Tiwari RK
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S86-93. PubMed ID: 12570340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulations of P450 mRNA in liver and mammary gland and P450 activities and metabolism of estrogen in liver by treatment of rats with indole-3-carbinol.
    Horn TL; Reichert MA; Bliss RL; Malejka-Giganti D
    Biochem Pharmacol; 2002 Aug; 64(3):393-404. PubMed ID: 12147290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity.
    Liu H; Wormke M; Safe SH; Bjeldanes LF
    J Natl Cancer Inst; 1994 Dec; 86(23):1758-65. PubMed ID: 7966413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Benzyl-indole-3-carbinol is a novel indole-3-carbinol derivative with significantly enhanced potency of anti-proliferative and anti-estrogenic properties in human breast cancer cells.
    Nguyen HH; Lavrenov SN; Sundar SN; Nguyen DH; Tseng M; Marconett CN; Kung J; Staub RE; Preobrazhenskaya MN; Bjeldanes LF; Firestone GL
    Chem Biol Interact; 2010 Aug; 186(3):255-66. PubMed ID: 20570586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes.
    Meng Q; Qi M; Chen DZ; Yuan R; Goldberg ID; Rosen EM; Auborn K; Fan S
    J Mol Med (Berl); 2000; 78(3):155-65. PubMed ID: 10868478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-estrogenic activities of indole-3-carbinol in cervical cells: implication for prevention of cervical cancer.
    Yuan F; Chen DZ; Liu K; Sepkovic DW; Bradlow HL; Auborn K
    Anticancer Res; 1999; 19(3A):1673-80. PubMed ID: 10470100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol metabolism: an endocrine biomarker for modulation of human mammary carcinogenesis.
    Telang NT; Katdare M; Bradlow HL; Osborne MP
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):559-64. PubMed ID: 9167995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane.
    Chen I; McDougal A; Wang F; Safe S
    Carcinogenesis; 1998 Sep; 19(9):1631-9. PubMed ID: 9771935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional aspects of the action of indole-3-carbinol as an antitumor agent.
    Bradlow HL; Sepkovic DW; Telang NT; Osborne MP
    Ann N Y Acad Sci; 1999; 889():204-13. PubMed ID: 10668495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells.
    Cover CM; Hsieh SJ; Cram EJ; Hong C; Riby JE; Bjeldanes LF; Firestone GL
    Cancer Res; 1999 Mar; 59(6):1244-51. PubMed ID: 10096555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium.
    Chen DZ; Qi M; Auborn KJ; Carter TH
    J Nutr; 2001 Dec; 131(12):3294-302. PubMed ID: 11739883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells.
    Meng Q; Yuan F; Goldberg ID; Rosen EM; Auborn K; Fan S
    J Nutr; 2000 Dec; 130(12):2927-31. PubMed ID: 11110848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
    Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
    Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol.
    Kojima T; Tanaka T; Mori H
    Cancer Res; 1994 Mar; 54(6):1446-9. PubMed ID: 8137246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans.
    Michnovicz JJ; Adlercreutz H; Bradlow HL
    J Natl Cancer Inst; 1997 May; 89(10):718-23. PubMed ID: 9168187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.